{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-064446","form_type":"8-K","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2025-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.536238+00:00","generated_at":"2026-05-18T06:19:50.462705+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Apimeds appoints Dr. Susan Kramer SVP Development, Brian Peters to lead ai² division","bullets":["Dr. Susan Kramer appointed SVP of Development; 30+ years experience including 18 at Genentech.","Brian Peters joins as Head of ai² division; previously Chief Strategy & Insights Officer at Heller Agency.","CEO Erik Emerson says strengthening operational leadership is a priority since IPO.","Dr. Kramer will oversee all product development; Peters will lead ai² platform strategy and launch.","Both appointments effective July 15, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-064446","json":"https://secwatch.observer/filing/0001213900-25-064446.json","markdown":"https://secwatch.observer/filing/0001213900-25-064446.md","text":"https://secwatch.observer/filing/0001213900-25-064446.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/0001213900-25-064446-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390025064446/ea0249160-8k_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T06:19:50.462705+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}